Skip to main content

Search

About
Partners
Case studies
Publications
Stakeholders
News
Contact
Recommendations

PREFER

About
Case studies
Events
Stakeholders
News
- @IMI_PREFER on Twitter
Partners
People
Publications
Contact
Recommendations

PREFER News @IMI_PREFER on Twitter

About
Case studies
Events
Stakeholders
News
- @IMI_PREFER on Twitter
Partners
People
Publications
Contact
Recommendations

@IMI_PREFER on Twitter

Tweets by IMI_PREFER

Contact us

contact@imi-prefer.eu

communications@imi-prefer.eu

Follow us on twitter: @IMI_PREFER or YouTube

Subscribe to our newsletter

Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.

Shortcuts

Our Stakeholders

ProjectPlace login

Dissemination proposal form

Accessibility report for imi-prefer.eu

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

This site is hosted by Uppsala University

This website uses cookies to make your website experience as good as possible.